BRYNELSEN CHARLES 4
4 · ABBOTT LABORATORIES · Filed Feb 25, 2020
Insider Transaction Report
Form 4
BRYNELSEN CHARLES
Senior Vice President
Transactions
- Award
Common shares without par value
2020-02-21+12,500→ 51,961 total - Award
Option (right to buy)
2020-02-21+76,198→ 76,198 totalExercise: $87.72From: 2021-02-21Exp: 2030-02-20→ Common shares (76,198 underlying)
Footnotes (2)
- [F1]These shares represent a performance-based restricted stock award under the Abbott Laboratories 2017 Incentive Stock Program. The award has a 3-year term, with no more than 1/3 of the award vesting in any one year upon Abbott reaching a minimum return on equity target. The award includes the right to have shares withheld for tax purposes.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. The option becomes exercisable in annual increments of 25,399 on February 21, 2021, 25,399 on February 21, 2022, and 25,400 on February 21, 2023.